TGA Approval

RINVOQ upadacitinib 45 mg modified release tablet blister pack (375857)

ARTG ID

375857

ARTG Name

RINVOQ upadacitinib 45 mg modified release tablet blister pack

Sponsor

AbbVie Pty Ltd

ARTG Date

September 20, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ABBVIE PTY LTD

https://medical-cdn.nocode.com/drug_tga/7bb56c02342a7bec3d9dc58f23d11e97.pdf

https://medical-cdn.nocode.com/drug_tga/f1ef25397dc91604d09c47624262cacb.pdf

Ingredient Name

upadacitinib hemihydrate

Empowering clinical research with data-driven insights and AI-powered tools.

RINVOQ upadacitinib 45 mg modified release tablet blister pack (375857) - TGA 批准文号 | MedPath